-
Goldman Sachs Raises PT On Rite Aid To $1.40
Monday, June 27, 2011 - 7:13amGoldman Sachs has raised the price target on Rite Aid (NYSE: RAD) from $1.25 to $1.40 and maintains its Neutral rating.
Read More >> -
Three Reasons Investors Should Sell Rite Aid (RAD)
Friday, March 12, 2010 - 1:23pmThe Motley Fool's Dave Mock wrote an article today on 3 Reasons to Sell Rite Aid Today. The first reason given by Mock for investors to consider selling Rite Aid Corporation (NYSE: RAD) was that the drugstore chain consistently loses money. The second reason provided was that same-store sales have...
Read More >>
